“It is better to have a short life that is full of what you like doing than a long life spent in a miserable way.”
— Alan Watts
Governed Biotech
Intelligence
We don't create complexity. We reveal clarity.
The Moment
The gap between the headliner and the “never-was” is razor thin. Most people treat the PDUFA date as the defining moment in a brand's life. We believe there's an earlier one that matters just as much: the trial submission window.
History remembers the breakthroughs. It doesn't remember the 93% that never reach approval1, the time, the money, the years of real work, reduced to a footnote, or nothing at all. Many of those failures weren't scientific. They were operational. A signal someone else could have caught, but didn't see in time.
Solvynt exists to find that signal before it gets lost in the noise, while there's still an opportunity to act on it. Getting the pre-launch window right isn't a competitive advantage. It's the price of admission to tomorrow.
¹ PhRMA, Norstella, Sedulo Group, PR Newswire
Philosophy
Speed without governance is exposure, not advantage.
Confirmation bias doesn't need speed. It needs a way in.
We took a different approach to AI: built to break bias, not confirm it, surfacing untapped market potential in the process.
We aren't in the pattern recognition game.
We are governed conviction.
People
Fifty-eight years combined experience across strategy, media, technology, and finance. The real asset, though, is what that diversity affords us.
We see the whole field before we ever step onto it. Separate backgrounds provide a genuine range of ways to approach a challenge, sharpened by people wired differently from the start.
Earned in the trenches, as friends. That kind of history buys you something most teams never get: the standing to disagree, hard, and still be heard without breaking under pressure. It's been tested for decades, long before there was a company riding on it.
